
Starting at$50/ mowith a 12-week plan
Choose options
Semaglutide
Active ingredient
glycine
Active ingredient
Follow the dosing directions approved by your clinician.
Weight loss by dose
Estimated share of body weight lost at each weekly dose, beyond diet and exercise alone, from a 52-week clinical trial of semaglutide.
micro0.4 mg a week, your selected dose
An estimated 4.1%
standard0.9 mg a week
An estimated 7.2%
advanced1.4 mg a week
An estimated 9.3%
Estimated for our doses from the dose groups of a 52-week phase 2 trial of once-daily semaglutide in 957 adults without diabetes (O'Neil et al., Lancet 2018), minus the 2.3% the placebo group lost with the same diet and exercise counseling. We compare weekly totals: its 0.05, 0.1 and 0.2 mg a day groups took 0.35, 0.7 and 1.4 mg a week. Our 1.4 mg matches that 1.4 mg a week total; 0.4 and 0.9 mg are drawn on a straight line between groups. The trial used manufacturer-made semaglutide, not a compounded medication. Compounded medications are not FDA-approved. Individual results vary.
Price comparison
Each provider's starting dose of semaglutide, per month, including any membership.
Each provider's starting dose, per month, including any required membership, on the plan closest to our 12-week prepay (3-month plans where offered, otherwise month-to-month). Ro and Hims & Hers sell brand-name Wegovy, not compounded semaglutide. Compounded medications are not FDA-approved.
Starting at$60.71/ mowith a 12-week plan
Choose optionsStarting at$60.71/ mowith a 12-week plan
Choose options